Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 10 Sept 2026 for CONMED Corp. Read the official filing
Filing timeline
BuySaleKim Kelderman
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kim Kelderman: trading record in brief
Filings by Kim Kelderman span 2 companies, the busiest being BIO-TECHNE Corp and CONMED Corp. Between 1 May 2021 and 8 September 2026, the trades on record add up to 31 filings.
The open-market record consists of 3 sales worth €953k, with no purchase. Other entries cover 9 share grants and 19 option exercises.
On 10 September 2026 came the latest disclosure, an option exercise in CONMED Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kim Kelderman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
500 shares0Common StockSEC:0000816956-26-000105:0
21,470 shares0Common StockSEC:0000914190-26-000122:0
10,821 shares@ US$72.400.0070% mcap5.5% of flowCommon StockSEC:0000914190-26-000122:1
28,686 shares@ US$72.070.019% mcap15.5% of flowCommon StockSEC:0000914190-26-000106:1
35,000 shares@ US$47.600.015% mcap12.5% of flowCommon StockSEC:0000914190-26-000106:0
11,344 shares0Common StockSEC:0000914190-26-000081:0
1,363 shares@ US$58.580.0007% mcap1.4% of flowCommon StockSEC:0000914190-26-000081:1
36,500 shares0Common StockSEC:0000914190-26-000070:0
32,088 shares@ US$58.660.017% mcap24.9% of flowCommon StockSEC:0000914190-26-000070:1
2,303 shares@ US$62.571.5% of flowCommon StockSEC:0000914190-25-000031:0
8,543 shares0Common StockSEC:0001062993-25-014700:0
48,176 shares@ US$44.3321.8% of flowCommon StockSEC:0001062993-25-013134:0
36,132 shares@ US$44.3316.6% of flowCommon StockSEC:0001062993-25-012967:0
13,392 shares@ US$37.7010.2% of flowCommon StockSEC:0001062993-25-001237:0
2,430 shares@ US$75.313.5% of flowCommon StockSEC:0001062993-24-018334:0
1,492 shares@ US$66.971.9% of flowCommon StockSEC:0001062993-24-015997:0
14,000 shares@ US$37.7010.3% of flowCommon StockSEC:0001062993-24-014366:0
14,196 shares0Common StockSEC:0001062993-23-020118:0
2,100 shares@ US$47.601.9% of flowCommon StockSEC:0001062993-23-017156:0
4,139 shares@ US$82.176.5% of flowCommon StockSEC:0001062993-23-016036:1
8,060 shares0Common StockSEC:0001062993-23-016036:0
663 shares@ US$150.782.1% of flowCommon StockSEC:0001437749-22-021367:0
1,214 shares@ US$382.979.6% of flowCommon StockSEC:0001437749-22-019667:1
2,363 shares0Common StockSEC:0001437749-22-019667:0
1,989 shares@ US$150.782.2% of flowCommon StockSEC:0001437749-22-003021:0
25 of 31 declarations
